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Summary
Embryonic Stem (ES) cells are able to give rise to the three
germ layers of the embryo but are prevented from
contributing to the trophoblast. The molecular nature of this
barrier between embryonic and trophectodermal cell fates is
not clear, but is known to involve DNA methylation. Here we
demonstrate that the Nucleosome Remodeling and
Deacetylation (NuRD) co-repressor complex maintains the
developmental barrier between embryonic and
trophectodermal cell fates by maintaining transcriptional
silencing of trophectoderm determinant genes in ES cells. We
further show that NuRD activity facilitates DNA methylation
of several of its target promoters, where it acts non-
redundantly with DNA methylation to enforce
transcriptional silencing. NuRD-deficient ES cells fail to
completely silence expression of the trophectoderm
determinant genes Elf5 and Eomes, but this alone is not
sufficient to induce transdifferentiation towards the
trophectoderm fate. Rather this leaves ES cells capable of
activating expression of trophectoderm-specific genes in
response to appropriate extracellular signals, enabling them
to commit to a trophectodermal cell fate. Our findings clarify
the molecular nature of the developmental barrier between the
embryonic and trophoblast cell fates, and establish a role for
NuRD activity in specifying sites for de novo DNA methylation.
 2012. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
The first lineage commitment event during early mammalian
development results in the segregation of two distinct cell types
in the early blastocyst: the inner cell mass (ICM), which will go
on to form all cell types in the embryo, and the trophectoderm
(TE), which will give rise to placental tissues (Johnson and
McConnell, 2004). Embryonic stem (ES) cells and trophoblast
stem (TS) cells can be derived from implantation-stage embryos
and maintained indefinitely in culture, while retaining many
features of early embryonic cells (Evans and Kaufman, 1981;
Martin, 1981; Ralston and Rossant, 2005; Tanaka et al., 1998).
ES cells can differentiate further into the three germ layers:
mesoderm, endoderm and ectoderm, but are excluded from the
trophoblast fate. In contrast, TS cells can give rise to trophoblast
derivatives but are prevented from differentiating into the three
germ layers.
A specific combination of epigenetic modifications and
transcription factors orchestrates the distinctive potentials of ES
cells and TS cells, imposing a barrier that prevents trans-
differentiation once fate is established (Niwa, 2007; Ralston and
Rossant, 2005). This potency barrier faced by ES cells can be
overcome, however, through forced expression of TS cell-
specific transcriptional factors, which allows ES cells to
convert into TS cells (Gu et al., 2011; Ng et al., 2008; Niwa et
al., 2005). Similarly, ES cells mutant for the DNA
methyltransferases, and therefore deficient for DNA
methylation-mediated transcriptional silencing, are able to
commit to the TE lineage (Ng et al., 2008; Sakaue et al.,
2010). These observations indicate that the barrier between ES
and TS cell fates is maintained through control of gene
expression.
DNA methylation is associated with transcriptional repression
and is essential for embryonic development (Li et al., 1992;
Okano et al., 1999). While dispensable for ES cell self-renewal,
TS cell self-renewal and TS cell differentiation, DNA
methylation is essential for ES cell differentiation (Jackson et
al., 2004; Lei et al., 1996; Okano et al., 1999; Sakaue et al.,
2010). Vertebrate genomes are globally methylated, with the
most notable exceptions being CpG-rich stretches of DNA,
termed CpG islands, located at the 5’ ends of many genes (Bird,
2002). In ES cells the vast majority of CpG islands remain











predominantly expressed in the germline (Fouse et al., 2008;
Meissner et al., 2008; Mohn et al., 2008). Exactly how de novo
DNA methylation is targeted to specific regions of DNA is not
well understood, although chromatin-remodeling proteins have
been shown to be important for the establishment and/or
maintenance of DNA methylation patterns (Bourc’his and
Bestor, 2002; Klose and Bird, 2006).
The Nucleosome Remodeling and Deacetylation (NuRD)
complex is a multiprotein co-repressor complex that regulates
developmental transitions in embryos and ES cells (McDonel et
al., 2009). ES cells lacking Mbd3, a structural NuRD component
protein, are viable but are unable to commit to differentiation
upon withdrawal of self-renewal signals (Kaji et al., 2006).
NuRD-mediated deacetylation can direct the activity of the
polycomb repressive complex 2 (PRC2) to silence gene
expression (Reynolds et al., 2011), and NuRD has also been
implicated in directing DNA methylation to a target gene in
leukaemia cells (Morey et al., 2008). Mbd3-deficient ES cells
have been shown to inappropriately express trophectoderm-
specific genes in certain conditions (Kaji et al., 2006; Zhu et al.,
2009). The extent to which NuRD-deficient ES cells can cross the
ES-TS barrier, or whether NuRD and DNA methylation act upon
the same genes to prevent misexpression of TE markers have not
previously been explored.
Here we undertake a molecular investigation into the nature of
the NuRD-dependent block that normally restricts ES cells away
from a TE cell identity. We find that NuRD activity facilitates
DNA methylation of a number of its target genes and repetitive
elements in ES cells, including the TE determinant gene Elf5. We
further show that NuRD-dependent transcriptional silencing of
both Elf5 and Eomes renders ES cells insensitive to TE-inducing
extracellular signals. These experiments show that NuRD activity
and DNA methylation function in a non-redundant manner to
restrict the developmental potential of pluripotent cells, effectively
constructing a barrier between ES cell and TS cell fates.
Results
Reversible hypomethylation at promoters and constitutive
heterochromatin in NuRD-deficient ES cells
A number of genes reportedly regulated by DNA methylation
show elevated expression levels in Mbd32/2 ES cells (Fig. 1A,B)
(Reynolds et al., 2011). This included genes normally expressed
in the germ line (Sohlh2, Dazl, and Tex13) and the trophectoderm
determinant gene Elf5 (Maatouk et al., 2006; Ng et al., 2008).
Bisulphite sequencing near the transcription start site of each
gene verified that all of these genes show a considerable degree
of DNA methylation in wild type ES cells (Fig. 1C). In contrast
DNA methylation levels were much reduced at all of these
promoters in Mbd3-null ES cell lines, consistent with the
increased expression levels seen for the corresponding genes
(Fig. 1C). The majority of genes showing NuRD-dependent
silencing in ES cells do not normally show DNA methylation at
their promoters in ES cells (Reynolds et al., 2011) (e.g. Fig. 1D;
Htra1 and Ppp2r2c). Thus we conclude that DNA methylation is
directed to a relatively small subset of NuRD target genes.
Ectopic expression of Mbd3b in Mbd32/2 ES cells restores
NuRD function (Kaji et al., 2006) and results in reimposition of
transcriptional silencing at NuRD target genes (Fig. 1A).
Restoring NuRD function to mutant cells also resulted in the
re-establishment of DNA methylation to near wild type levels
(Fig. 1C). The fact that promoters re-gain DNA methylation
levels indicates that restoration of NuRD activity targets them for
de novo DNA methylation. Thus the ability of ES cells to
methylate these promoter sequences depends more on NuRD
activity than on the existing DNA methylation pattern.
DNA methylation at constitutive heterochromatic sequences
such as major satellite, minor satellite, and IAP elements, was
also found to be much reduced in NuRD-deficient ES cells using
methylation-sensitive restriction digests and Southern blotting
(Fig. 2A,B). As with the euchromatic sequences, this loss of
methylation was rescued upon reintroduction of Mbd3 to the
Mbd32/2 ES cells, demonstrating that the ability of ES cells to
methylate satellite sequences is intimately linked to their ability
to form the NuRD complex. Despite being important for
methylation of these heterochromatic sequences, absence of
NuRD activity does not have a detectable effect upon global
levels of 5-methylcytosine (Fig. 2C).
Global gene expression analysis (Reynolds et al., 2011)
indicated reduced levels of Dnmt3b transcripts and elevated
levels of Dnmt3l transcripts in Mbd3-null ES cells (Fig. 1B). In
contrast no significant changes in the levels of Dnmt3a or Dnmt1
transcripts were detected. While decreased levels of Dnmt3b
protein could explain the observed hypomethylation of minor
satellite repeats (Okano et al., 1999), the fact that we also see
hypomethylation at major satellites, IAPs, and single-copy
sequences indicates that this is unlikely to be the only
explanation for the demethylation seen in Mbd32/2 ES cells.
Therefore, as NuRD does not control global DNA methylation
levels in ES cells (Fig. 2C), we conclude that loss of DNA
methylation is a particular feature of satellite sequences and a
relatively small subset of genes subjected to NuRD-dependent
transcriptional control in ES cells.
NuRD represses early trophectoderm markers in ES cells
One of the genes demethylated and inappropriately expressed in the
absence of NuRD activity was Elf5. Elf5 has been reported to serve
as an epigenetically regulated gatekeeper between embryonic and
trophoblast fates in embryonic stem cells (Ng et al., 2008). This
fact, combined with observations that ES cells lacking Mbd3, or in
which Mbd3 has been knocked down, are able to express markers of
TE (Kaji et al., 2006; Zhu et al., 2009), led us to further investigate
the relationship between NuRD function, Elf5 misexpression, and
the barrier between embryonic and TE cell fates.
While expression of trophoblast markers in NuRD-deficient
ES cells has been reported by us and by others (Kaji et al., 2006;
Zhu et al., 2009), in neither study was it demonstrated whether
this was due to actual transdifferentiation of ES cells towards a
TE fate, or simply due to a failure of transcriptional silencing of
TE markers. Mbd32/2 ES cells can be maintained for several
years in self-renewing conditions without adopting a trophoblast
morphology, ruling out any suggestion that Mbd3 is required to
prevent transdifferentiation of ES cells to TE (B.H. lab,
unpublished observations). Indeed, we only detect expression of
markers of differentiated TE in Mbd3-null ES cells after more
than five days’ culture as embryoid bodies (Kaji et al., 2006).
Therefore we assessed TE differentiation in wild type, Mbd32/2
ES cells and Mbd3b-rescued Mbd32/2 ES cells subjected to an
extended differentiation protocol. ES cells were cultured in
suspension for five days and then plated on gelatinized dishes in
ES media without LIF, and then monitored for the emergence of
cells showing trophoblast giant cell morphology. Three weeks
after plating, cells containing very large nuclei and expressing the










Fig. 1. Gene expression and DNA methylation changes in Mbd32/2 ES cells. (A) Expression levels of indicated genes in Mbd32/2 ES cells (black) and Mbd32/2
ES cells rescued with an Mbd3b transgene (grey) are displayed relative to that seen in Mbd3Flox/- ES cells. Error bars represent SEM from >3 biological replicates.
All genes shown except Pou5f1 show significant misexpression in null cells (p,0.001 using a two tailed t-test). (B) Expression data from Illumina bead arrays as
reported (Reynolds et al., 2011). (C) Summary of bisulphite sequencing results at the promoters of the indicated genes in Mbd3Flox/- ES cells (Flox/-), Mbd32/2 ES
cells (KO), and Mbd32/2 ES cells in which Mbd3 expression was restored with an Mbd3b-expressing transgene (KO:Mbd3b). Sequences covered by the bisulphite
analysis are indicated below the gene name, relative to the major transcription initiation site. Filled circles indicate methylated CpG dinucleotides, open circles
represent unmethylated CpG dinucleotides. The percentage of methylated CpG dinucleotides is indicated below each panel. (D) Results of bisulphite sequencing in
Mbd3Flox/- ES cells (Flox/-) and Mbd32/2 ES cells (KO) at the promoters of Htra1 and Ppp2r2c. Sequences covered by the bisulphite analysis are indicated below the
gene name, relative to the major transcription initiation site.










trophoblast markers Elf5, Prl3d1 (PL-1) and Prl3b1 (PL-2) could
be readily identified in Mbd32/2 cultures, consistent with the
formation of trophoblast cells, but not in cultures made from wild
type or Mbd3b rescued ES cells (Fig. 3A,B). These observations
are consistent with a model in which Mbd3-null ES cells are
capable of transdifferentiation towards a trophoblast fate after
prolonged exposure to differentiation conditions.
We suspected that a failure of appropriate transcriptional
silencing at Elf5, and possibly other genes, left Mbd3-null ES
cells permissive for trophoblast differentiation. Consistent with
Fig. 2. Global analysis of DNA methylation in Mbd32/2 ES cells. Genomic DNA from parental ES cells (+/2), Mbd32/2 ES cells (2/2) or from ES cells
expressing only Mbd3a, Mbd3b or Mbd3c was digested with MspI (M) and HpaII (H) (A) or with HpyCH4IV (B) before being Southern blotted and hybridised with
probes for the minor (A) or major satellite DNA repeats (B), or for IAP LTRs (A). Mito: mitochondrial DNA probe used as a loading and digestion control. (C) Total
5-methylcytosine levels were quantitated in two different Mbd3Flox/- ES cell lines (WT1 and WT2) and two different Mbd32/2 ES cell lines (KO1 and KO2) by HPLC
and mass spectrometry. Error bars represent SEM of three technical replicates.










this hypothesis, misexpression of Eomes, another early TE
determinant, was also detectable in undifferentiated Mbd32/2 ES
cells by microarray (Fig. 1B) (Reynolds et al., 2011). In contrast
expression of Cdx2 was found to be reduced in Mbd32/2 ES cells
below the already very low level seen in wild type ES cells
(Fig. 1B). These data were verified by quantitative RT-PCR
(Fig. 3C). Culturing ES cells in media used to support TS cell
maintenance (fibroblast conditioned media including Fgf4 and
heparin (Himeno et al., 2008)) resulted in a slight increase of Eomes
expression and substantial, further increase of Elf5 expression only
in the mutant cultures, but no activation of Cdx2 was detected
(Fig. 3C–E). Immunofluorescence revealed widespread co-
expression of Oct4 and Eomes in Mbd3-null cultures subjected to
TS conditions, consistent with a widespread conversion from an ES
to TS cell identity (Fig. 3D). As expected for TS cells (Tanaka et
al., 1998), withdrawal of Fgf4 resulted in expression of markers of
differentiated trophoblast Prl3d1 and Prl3b1 in Mbd32/2 cultures
but not in wild type or Mbd3b rescued cells (Fig. 3F), indicating
that the TS-like cells derived from Mbd32/2 ES cells are able to
differentiate into trophoblast derivatives. We conclude that NuRD
blocks the very first steps in TE differentiation in ES cells by
maintaining transcriptional silencing of the early trophoblast
specification genes Elf5 and Eomes.
Forced expression of Elf5 in ES cells has been reported to result in
activation of both Cdx2 and Eomes (Ng et al., 2008), yet in our
cultures Cdx2 activation did not parallel Elf5 expression. To
investigate this discrepancy we overexpressed an epitope tagged
version of Elf5 in wild type ES cells using the strong CAG promoter
(supplementary material Fig. S1). This resulted in a robust induction
of Eomes but not of Cdx2, demonstrating that Elf5 overexpression
does not necessarily lead to Cdx2 induction. Thus conversion of
Mbd32/2 ES cells towards a TE fate is most likely driven by Elf5
and Eomes, while Cdx2, which has been shown to be dispensable for
the ES-to-TS conversion (Niwa et al., 2005), is not involved.
Depletion of Elf5 or Eomes restores the ES-TS barrier in
Mbd32/2 cells
In order to determine whether the loss of the NuRD-mediated
transcriptional silencing of Elf5 and Eomes underlies the loss of
the barrier normally preventing ES cells from adopting a
trophoblast cell fate seen in Mbd32/2 ES cells, we reduced the
transcript levels of Elf5 and Eomes using short hairpin RNAs
(shRNAs). Levels of Elf5 transcripts were depleted by
approximately 85%, and those of Eomes by approximately 60%
compared to levels seen in cells transfected with a scrambled
shRNA control (Fig. 4A). Control and knock-down lines were
maintained in TS media for 6 days, followed by 12 days of Fgf4
depletion. As shown in Fig. 4B, Mbd32/2 cells in which Elf5
levels were depleted showed significantly reduced levels of
markers of differentiated trophoblast (Prl3d1 and Tpbpa)
compared to Mbd32/2 cells transfected with the scrambled
control shRNA. Mbd32/2 cells in which Eomes levels were
decreased showed intermediate effects (Fig. 4B). These results
indicate that the inappropriate expression of Elf5, and to a lesser
extent Eomes, in the Mbd32/2 cells is responsible for the ability
of these cells to differentiate into trophoblast.
Failure of gene silencing, but not precocious transcriptional
activation in Mbd32/2 ES cells
In contrast to Elf5, activation of Eomes in the Mbd32/2 ES cells
cannot be explained by the loss of DNA methylation, since the
Eomes promoter is not methylated in ES cells (Ng et al., 2008).
NuRD has been shown to control levels of acetylation at lysine
27 of histone H3 (H3K27ac) at target promoters, which indirectly
regulates the levels of methylation at this same residue
(H3K27Me3) (Reynolds et al., 2011). Therefore we next
assessed the status of chromatin at the promoters of Eomes and
Elf5 in wild type and Mbd3-mutant ES cells. Chromatin
immunoprecipitation (ChIP) across the Eomes locus revealed a
significant loss of H3K27me3 and an increase in H3K4me3 and
H3K27ac in the Mbd32/2 ES cells compared to both wild type
and Mbd3b rescue ES cells (Fig. 5A), consistent with a loss of
silencing and gain of transcription at this locus. Similarly, a
substantial gain of the active histone marks H3K4me3 and
H3K27ac was observed around the Elf5 promoter in Mbd32/2 ES
cells compared to the wild type and Mbd3b rescue ES cells
(Fig. 5A). Further, the NuRD component protein Mi2b was
found to associate with both the Eomes and Elf5 promoters in
wild type ES cells (Fig. 5B), indicating that NuRD physically
associates with these promoters to maintain silent chromatin.
In self-renewing conditions, expression of Elf5 is elevated
approximately five-fold in the absence of a functional NuRD
complex, but after exposure to TS cell conditions for four days
expression increases a further ten-fold (Fig. 3C). This
observation led us to hypothesise that Mbd3-null ES cells
display a failure of silencing at Elf5, but not inappropriate
transcriptional activation. If this is the case, then transcriptional
activation of Elf5 should require the cells to begin to adopt a TE
fate, something that is critically dependent upon Fgf4 (Tanaka et
al., 1998). To test this idea, wild type and Mbd32/2 ES cells were
cultured in ES or TS conditions for 12 or 24 hours in the presence
of an Fgf4 receptor (Fgf4r) inhibitor (SU5402), as well as in an
inhibitor of Mek (PD184352), a downstream effector of the Fgf4
signaling pathway (Davies et al., 2000; Mohammadi et al., 1997)
or carrier only (DMSO) (Fig. 5C). Western blotting was used to
demonstrate that treatment of cells with either inhibitor for 12
hours was sufficient to completely block Erk phosphorylation
(supplementary material Fig. S2). The selective inhibition of
Fgf4r or Mek in TS media without Fgf4 does not alter Elf5
expression levels in either wild type or Mbd3-null cultures. In
contrast, supplementing the TS media with Fgf4 results in an
approximately two-fold further increase in Elf5 transcript levels
in Mbd32/2 ES cells after just 12 hours, and this effect is blocked
by either inhibitor (Fig. 5C). In contrast Eomes induction in
Mbd32/2 ES cells is not responsive to Fgf4 signaling (data not
shown). These data indicate that the Elf5 expression seen in
Mbd32/2 ES cells represents a basal expression level resulting
from a failure of silencing, rather than inappropriate induction, as
expression can be induced further by addition of Fgf4 and
activation of the Mek/Erk pathway. Thus we suggest that
transcriptional silencing by NuRD at the Elf5 and Eomes
promoters, which involves both histone modification and DNA
methylation, normally prevents ES cells from being able to
respond to external signals that would otherwise induce
differentiation along the TE lineage.
Discussion
ES cells, and the inner cell mass cells from which they are
derived, are able to differentiate into mesoderm, endoderm and
ectoderm but are normally prevented from forming trophoblast.
Ectopic expression of normally silent transcription factors has
been shown to allow ES cells to overcome this differentiation










Fig. 3. See next page for legend.










barrier and adopt the normally inaccessible TE fate (Gu et al.,
2011; Ng et al., 2008; Niwa et al., 2005). This provides evidence
that the nature of the differentiation barrier faced by ES cells is
likely to be maintained by the ability of those cells to repress
expression of certain genes. Consistent with this idea, Hemberger
and colleagues found that ES cells in which the maintenance DNA
methyltransferase Dnmt1 is mutated lack this differentiation
barrier (Ng et al., 2008). Here we demonstrate that
transcriptional silencing by the NuRD complex, which at some
genes involves specification of DNA methylation, also contributes
to this differentiation barrier by maintaining repression of the
TE-specific transcription factor genes Elf5 and Eomes.
We draw a distinction between failure of silencing and
activation of TE determinant genes. While ES cells lacking
Mbd3 show precocious transcription of both Elf5 and Eomes,
expression levels remain much lower than is seen when TS
differentiation is induced with Fgf4. In contrast Fgf4 stimulation
does not induce TE differentiation in wild type cells in which
Elf5 silencing is maintained (Fig. 5C). It has been reported that
Mek/Erk signaling plays a crucial role in the trophoblast
compartment where it promotes expression of Cdx2 and then in
turn of Elf5 (Krueger et al., 2009; Lu et al., 2008). As we observe
Elf5 up-regulation but do not detect expression of Cdx2 upon
Fgf4 stimulation in Mbd32/2 cells (Fig. 3C), we speculate that
Elf5 may be a direct target of Mek/Erk signaling. Our findings
are consistent with a model in which NuRD-mediated, DNA
methylation-dependent silencing at Elf5 can act as a switch
(Fig. 6): in the on state (i.e. absence of Elf5 silencing) cells are
able to respond to external trophoblast-inducing differentiation
cues (i.e. Fgf4). However when in the off state (Elf5 expression
completely repressed) cells can no longer respond to this signal
and do not initiate differentiation towards TE.
Fig. 3. Mbd32/2 ES cells differentiate into trophoblast. (A) Immunofluorscence labeling of wild type (wt) and Mbd32/2 (KO) embryoid bodies for Prl3d1 (Pl1, a
giant cell marker) and Elf5 (a diploid trophoblast marker). Scale bars represent 113mm. (B) Expression levels of giant cell markers Prl3d1 and Prl3b1 (Pl2) in wild
type (wt), Mbd32/2 (KO) and Mbd32/2 line rescued with a Mbd3b transgene (KO:M3b) grown as ES cells (ES) and embryoid bodies (EB). Error bars represent
S.E.M of three biological replicates. (C) Expression levels of TS markers Eomes, Elf5 and Cdx2 in wild type (wt), Mbd32/2 (KO) and Mbd32/2 rescued with a
Mbd3b transgene (KO:M3b) ES lines grown in ES (d0) and TS (d4, d6) conditions. Wild type TS line (TS) was used as a positive control for Cdx2 expression. Error
bars represent S.E.M of three biological replicates. (D) Double immunofluorescence labeling for Eomes and Oct4 in wild type (wt) and Mbd32/2 (KO) ES lines
grown for 4 days in TS conditions. Scale bars represent 35mm. (E) Immunofluorescence staining of Cdx2 in wild type (wt) and Mbd32/2 (KO) ES lines grown for 4
days in TS conditions in comparison to wild type TS line (TS). Scale bars represent 35mm. (F) Expression levels of Prl3d1 and Prl3b1 in wild type (wt), Mbd32/2
(KO) and Mbd32/2 rescued with a Mbd3b transgene (KO:M3b) ES lines grown for 6 days in TS media and then for further 12 days in absence of Fgf4. (Note that d0
refers to the cells kept for 6 days in full TS media). Error bars represent S.E.M of three biological replicates.
Fig. 4. Depletion of Elf5 or Eomes in Mbd32/2ES cells prevents trophoblast differentiation. (A) Expression levels of Elf5 (left panel) and Eomes (right panel) in
wild type ES cells (wt) or in Mbd32/2 ES cells (Mbd3KO) expressing control shRNA (scr), shRNA directed against Elf5 (Elf5) or Eomes (Eom) are displayed relative
to expression levels in wild type ES cells. (B) Expression levels of Prl3d1 and Tpbpa in control (scr), Elf5 depleted (Elf5) and Eomes depleted (Eom) Mbd3-null ES
cell lines grown for 6 days in TS media and then for further 12 days in absence of Fgf4. Note that d0 refers to the cells kept for 6 days in full TS media.










Fig. 5. See next page for legend.










It was surprising that overcoming the developmental barrier
between ES cells and TS cells in Mbd32/2 cultures did not
involve activation of the canonical TE marker Cdx2. Mbd32/2
embryos express Cdx2 appropriately in early TE cells,
demonstrating that Mbd3 is not required for Cdx2 expression in
vivo (Kaji et al., 2007) (B.H., unpublished), are able to implant in
vivo and to outgrow ex vivo, indicating functionality of early
Mbd32/2 TE (Hendrich et al., 2001; Kaji et al., 2007). Similarly,
Mbd32/2 TS cells show no abnormalities in Cdx2 expression
patterns (P.A.L., K. Kaji and B.H., unpublished). The absence of
Cdx2 induction in Mbd3-null ES cells was intriguing as it has
been reported that Elf5, Eomes and Cdx2 regulate each other in a
positive feed-back loop (Ng et al., 2008). Nevertheless it has been
shown that forced expression of Eomes in ES cells can give rise
Fig. 5. Mbd32/2 ES cells show active chromatin marks around Elf5 and Eomes promoters. (A) Chromatin immunoprecipitation (ChIP) using anti-histone H3 tri-
methylated at lysine 4 (H3K4me3), anti-histone H3 acetylated at lysine 27 (H3K27ac), anti-histone H3 tri-methylated at lysine 27 (H3K27me3) and control IgG
antibodies performed on wild type (wt; black line), Mbd32/2 (KO; red line) and rescued (KO:M3b; grey line) ES cells. Identically color-coded dashed lines indicate
control IgG immunoprecipitation in the three ES lines. Immunoprecipitates were probed with primer pairs located at indicated positions relative to the transcriptional
start site (X-axis). The Y-axis represents the results plotted as percentage of input. Error bars represent S.E.M of three biological replicates. (B) Chromatin
immunoprecipitation using a-Mi2b antibody and control IgG antibodies in wild type ES cells. Immunoprecipitates were probed with primer pairs located at indicated
positions relative to the transcriptional start site (X-axis). The Y-axis represents the results plotted as percentage of input. Error bars represent S.E.M of three
biological replicates. (C) Expression levels of Elf5 in wild type (wt) and Mbd32/2 (KO) ES lines grown for 12 h (grey bar) or 24 h (black bar) in complete TS media
(TS+Fgf4) or without Fgf4 (TS) in presence of either 10 mM Mek1 inhibitor PD184352 (PD), 10 mM Fgf4 receptor inhibitor SU5402 (SU) or DMSO control (2).
Error bars represent S.E.M of three biological replicates.
Fig. 6. Model of NuRD function in ES cell self-
renewal and differentiation. ES cells (top) can self-
renew (circular arrow) or differentiate into one of the
three germ layers (endoderm, mesoderm, or ectoderm).
The path towards trophectoderm differentiation is
normally blocked through the action of the NuRD
complex and DNA methylation, which together maintain
silencing of trophectoderm specific genes. In the wild
type state trophectoderm determinant genes Elf5 and
Eomes are not expressed so ES cells are not responsive to
the presence of trophectoderm-inducing extracellular
signals such as Fgf4. Mbd32/2 ES cells (bottom) can
also self-renew but cannot commit to differentiate along
embryonic lineages. These cells lack a functional NuRD
complex and hence fail to completely silence Elf5 and
Eomes. Although the DNA methylation machinery is
largely intact, it is not directed towards Elf5 in the
absence of NuRD activity. While still capable of long-
term self renewal, the failure of Mbd32/2 ES cells to
completely silence Elf5 and Eomes expression leaves
them responsive to the presence of trophectoderm-
inducing extracellular signals such as Fgf4. When
exposed to such signals mutant cells can commitment
towards a trophoblast fate.










to trophoblast differentiation without the activation of Cdx2, and
that Cdx2 is not required to convert ES cells to TS cells in culture
(Niwa et al., 2005) indicating that Eomes may function
downstream of Cdx2 during TE formation (Fig. 6). Our results
are in agreement with the latter report suggesting that activation
of either Eomes or Elf5 does not necessarily lead to activation of
Cdx2 in ES cells.
Both NuRD activity and DNA methylation function to
maintain the lineage barrier between embryonic and trophoblast
cell fates. NuRD has previously been reported to be important for
de novo DNA methylation at the Rarb locus in leukemic cells
and, together with Dnmt3a, to mediate repression of the Pou5f1
gene in differentiating ES cells (Gu et al., 2011; Morey et al.,
2008). Here we show that NuRD activity facilitates DNA
methylation of a number of promoters and repetitive elements in
ES cells. Despite showing a loss of DNA methylation at both
major and minor satellite DNAs, quantification HPLC-MS/MS
revealed no overall difference in total 5-methylcytosine levels
between Mbd3-null and wild type ES cell lines. Such a
directional loss of DNA methylation, i.e. loss at satellite
sequences but no detectable change in overall DNA
methylation levels, has been described previously in human
cancer genomes (Feber et al., 2011), and may reflect some degree
of redistribution of DNA methylation across the genome.
Histone deacetylation by the NuRD complex has been shown
to direct the activity of PRC2 in ES cells (Reynolds et al., 2011).
We detect a direct association of a NuRD component on the Elf5
and Eomes promoters in wild type ES cells, which are normally
silent and embedded in chromatin displaying hallmarks of
transcriptional inactivity, such as DNA methylation and histone
hypoacetylation. Thus it is conceivable that the class I HDAC
activity contained within the NuRD complex normally serves to
maintain these genes in a hypoacetylated state, directing (or
allowing) both PRC2 and DNA methyltransferase activity to act
upon these target promoters.
That DNA methylation patterns are re-established upon
reformation of the NuRD complex indicates NuRD activity
makes some of its target sequences high probability targets for de
novo DNA methylation. Exactly how this works is not clear.
NuRD is known to influence histone methylation levels at both
H3K9 and H3K27 (Fig. 5; Reynolds et al., 2011), two marks that
have been implicated in recruiting de novo DNA
methyltransferase activity (Leung et al., 2011; Mohn et al.,
2008). Why NuRD activity can specify the Dazl promoter to be
methylated, for example, while the Ppp2r2c promoter remains
unmethylated irrespective of expression status, must lie in either
the DNA context or NuRD-independent chromatin context in
which these genes reside. No clear correlation exists between the
presence of DNA methylation, H3K27 trimethylation, or H3K4
trimethylation at these genes in wild type ES cells. Similarly,
strict CpG density is unlikely to explain specific methylation of
these genes, as the CpG islands associated with both Dazl and
Ppp2r2c have a similar observed over expected CpG ratio (0.76,
http://www.ensembl.org/Mus_musculus/Info/Index). The pre-
sence or absence of transcription factor binding sites within
CpG islands has recently been shown to influence the probability
of de novo DNA methylation (Lienert et al., 2011), although how
such binding would be NuRD-dependent also remains to be
elucidated.
NuRD’s role in maintaining the barrier between embryonic and
trophectodermal cell fates in ES cells exists side by side with its
function in facilitating embryonic lineage commitment (Fig. 6).
There is no evidence, however, that NuRD facilitates embryonic
lineage commitment by maintaining the barrier to TE
differentiation (Hargreaves and Crabtree, 2011). Mbd32/2 ES
cells are capable of long term self-renewal despite lacking the
ES-TS barrier, and after restoration of Mbd3 activity can
contribute to embryonic development (Kaji et al., 2006)
demonstrating that the ES-TS barrier is not required to prevent
TE differentiation of ES cells. Together our findings clarify the
nature of the epigenetic barrier between epiblast and trophoblast
cell fates, and define the role played by NuRD-mediated
transcriptional silencing in maintaining that barrier.
Materials and Methods
ES cell culture
Mbd3-null ES cell lines and floxed controls, Mbd3a-rescued and Mbd3b-rescued
ES cell lines have been described (Kaji et al., 2006). Mbd3c-expressing ES cells
were made as described (Aguilera et al., 2011). Mbd3b-rescued ES cells used for
trophectoderm experiments were made by expressing an Mbd3b transgene fused
to GFP in Mbd32/2 ES cells. ES cells were cultured on gelatin-coated dishes in
standard conditions. For embryoid body differentiation cells were first grown for
5 days in suspension in ES media without LIF and then plated on gelatin-coated
dishes for another 16 days. For transdifferentiation experiments 16105 cells
were plated on 6-well gelatin coated dishes and grown in standard TS media
(RPMI, 20% serum, 1 mM sodium pyruvate, 2 mM glutamine, 100 mM b-
mercaptoethanol, 25 ng/ml Fgf4, 1 mg/ml heparin) (Himeno et al., 2008), with
70% of the media preconditioned on mouse embryonic fibroblasts (MEFs). For
differentiation, cells were grown on gelatin in TS media without Fgf4 and
heparin.
Analysis of genomic DNA methylation
10 mg of genomic DNA was digested with HpyCH4IV, MspI or HpaII (New
England Biolabs), blotted and hybridised using standard methods. For bisulphite
sequencing, DNA was treated with sodium bisulphite as described (Herman et al.,
1996; Tremblay et al., 1997). Modified DNA was amplified by PCR
(supplementary material Table S1), cloned and sequenced. Primers were
designed using the Meth Primer programme: (http://www.urogene.org/
methprimer/index.html). At least ten sequences were examined for each CpG
site, except for the Elf5 promoter where at least 7 sequences were examined for
each site.
For quantification of global 5-methylcytosine content, genomic DNA samples
were boiled, treated with nuclease P1 (Sigma) for 16 h at 37 C̊, and with alkaline
phosphatase (Sigma) for an additional 2 h at 37 C̊. After hydrolysis, total
cytosine and 5mC content were measured by HPLC-MS in all samples. The LC-
ESI/MS system consisted of an Agilent Serie 1100 HPLC system coupled to an
Agilent LC/MSD VL mass spectrometer equipped with an electrospray ionization
source (Agilent Technology, Palo Alto, CA). 50 ml of the hydrolyzed-DNA
solution were injected onto an Atlantis dC18 column (2.16150 mm; 5 mm
particle size) protected by an Agilent guard column (2.1620 mm; 5 mm particle
size) at a constant flow of 0.220 ml min21. Two buffers, 0.1% formic acid in
water (Solvent A) and 0.1% formic acid in 50% water: 50% methanol (Solvent
B), were used, with a initial gradient of 5% solvent B, then an increase of
solvent B to 50% within 9 min and an isocratic gradient (50% of solvent B)
during 25 min. Electrospray source conditions were as described (Friso et al.,
2002) with minor modifications. A drying gas flow of 10.0 l.min21 was
employed, with auxiliary 35 psis gas to assit with nebulization and a drying
temperature of 350 C̊. The mass spectrophotometer was operated at a capillary
voltage of 4000 V, and spectra were collected in positive ion mode.
Identification of 29-deoxycytidine (dC) and 5-methyl-29-deoxycytidine (5mdC)
was obtained by UV detection at A254 and A280. Global DNA methylation levels
were calculated from integration peak areas of 5mdC relative to global cytidine
(5mdC + dC).
Immunofluorescence
Cells were fixed in 4% paraformaldehyde/PBS for 20 minutes at 4 C̊,
permeabilised and blocked for 30 minutes in 5% donkey serum/0.1% Triton
X-100/PBS. The following primary antibodies with given dilutions were used:
a-Cdx2 (1:200, Cell Marque), a-Eomes (1:200, ab23345, Abcam), a-Elf5 (1:200,
sc-9645, Santa Cruz), a-Pl1 (1:200, sc-34713, Santa Cruz) (supplementary
material Table S2). Alexa Fluor-conjugated secondary antibodies (Life
Technologies) were applied at 1/1000 in blocking solution. Cells were imaged
using a Zeiss AxioVert 200 microscope.










RNA knock-down and overexpression
Knock-down constructs containing shRNAs against Elf5 or Eomes were purchased
from Open Biosystems. Catalogue numbers and sequences targeted by the constructs
are listed in supplementary material Table S3. To establish stable knock-down lines
(KD), 16106 Mbd32/2 ES cells were transfected with 4.5 mg of plasmid using
Lipofectamine 2000 (Invitrogen) and after 24 hours subjected to 1 mg/ml puromycin
selection. Single clones were picked and analysed. For Elf5 overexpression, the Elf5
open reading frame was cloned into the pCAG-Avi-3xFlag-ires-puro vector and the
construct was elctroporated into Mbd3+/2 ES cells. Stable transfectants were
recovered following puromycin selection.
Quantitative PCR
Total RNA was prepared using TrizolH reagent (Life Technologies) and treated
with DNaseI (Promega). First-strand cDNA was synthesized using Superscript III
Reverse Transcriptase (Life Technologies). Quantitative PCR was performed using
Fast SYBR Green Master Mix (Life Technologies). Gene expression was
determined relative to Gapdh using the DDCt method. Error bars represent
S.E.M from at least 3 independent biological replicates. All quantitative PCR
reactions were performed in a 7900HT Fast Real-Time PCR System (Life
Technologies). Sequences of the PCR primers are listed in supplementary material
Table S4.
Chromatin Immunoprecipitation
Cells were fixed in 1% formaldehyde for 15 minutes at room temperature and
neutralized in 0.125 M glycine for 5 minutes followed by cell lysis (10 mM Tris-
HCl pH 8, 10 mM NaCl, 0.2% NP-40) on ice for 10 minutes and nuclei lysis
(50 mM Tris-HCl pH 8, 10 mM EDTA, 1% SDS) on ice for 10 minutes. Samples
were diluted (20 mM Tris-HCl pH 8, 2 mM EDTA, 150 mM NaCl, 0.01% SDS,
1% Triton X-100) and then sonicated using a Misonix 4000 microtip probe (12
cycles, 15 seconds on/45 seconds off). Chromatin was immunoprecipitated using
antibodies listed in supplementary material Table S2. DNA was assayed via
quantitative PCR using primers listed in supplementary material Table S5.
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M. and Schübeler, D. (2008). Lineage-specific polycomb targets and de novo DNA
methylation define restriction and potential of neuronal progenitors. Mol. Cell 30,
755-766.
Morey, L., Brenner, C., Fazi, F., Villa, R., Gutierrez, A., Buschbeck, M., Nervi, C.,
Minucci, S., Fuks, F. and Di Croce, L. (2008). MBD3, a component of the NuRD
complex, facilitates chromatin alteration and deposition of epigenetic marks. Mol.
Cell. Biol. 28, 5912-5923.
Ng, R. K., Dean, W., Dawson, C., Lucifero, D., Madeja, Z., Reik, W. and
Hemberger, M. (2008). Epigenetic restriction of embryonic cell lineage fate by
methylation of Elf5. Nat. Cell Biol. 10, 1280-1290.
Niwa, H. (2007). How is pluripotency determined and maintained? Development 134,
635-646.
Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R. and
Rossant, J. (2005). Interaction between Oct3/4 and Cdx2 determines trophectoderm
differentiation. Cell 123, 917-929.
Okano, M., Bell, D. W., Haber, D. A. and Li, E. (1999). DNA methyltransferases
Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian
development. Cell 99, 247-257.
Ralston, A. and Rossant, J. (2005). Genetic regulation of stem cell origins in the mouse
embryo. Clin. Genet. 68, 106-112.
Reynolds, N., Salmon-Divon, M., Dvinge, H., Hynes-Allen, A., Balasooriya, G.,
Leaford, D., Behrens, A., Bertone, P. and Hendrich, B. (2011). NuRD-mediated
deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to
direct gene repression. EMBO J. (in press).










Sakaue, M., Ohta, H., Kumaki, Y., Oda, M., Sakaide, Y., Matsuoka, C., Yamagiwa,
A., Niwa, H., Wakayama, T. and Okano, M. (2010). DNA methylation is
dispensable for the growth and survival of the extraembryonic lineages. Curr. Biol.
20, 1452-1457.
Tanaka, S., Kunath, T., Hadjantonakis, A. K., Nagy, A. and Rossant, J. (1998).
Promotion of trophoblast stem cell proliferation by FGF4. Science 282, 2072-2075.
Tremblay, K. D., Duran, K. L. and Bartolomei, M. S. (1997). A 5’ 2-kilobase-pair
region of the imprinted mouse H19 gene exhibits exclusive paternal methylation
throughout development. Mol. Cell. Biol. 17, 4322-4329.
Zhu, D., Fang, J., Li, Y. and Zhang, J. (2009). Mbd3, a component of NuRD/Mi-2
complex, helps maintain pluripotency of mouse embryonic stem cells by repressing
trophectoderm differentiation. PLoS ONE 4, e7684.
NuRD restricts ES cell potential 352
B
io
lo
g
y
O
p
e
n
